Issue: February 2014
January 15, 2014
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
FDA notified of oseltamivir oral suspension shortage
Issue: February 2014
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
There is currently a temporary shortage of oseltamivir oral suspension, according to an FDA press release.
Perspective from Edward A. Bell, PharmD, BCPS
Tamiflu (oseltamivir, Genentech) 30 mg, 45 mg, and 75 mg capsules remain available. Genentech expects additional Tamiflu Oral Suspension to be available by mid-January.
The FDA has provided for health care professionals the approved instructions on how to prepare an oral suspension from the 75-mg capsules. The instructions are available on the package insert and the FDA drug shortages website.